DP
PASG icon

Diadema Partners’s Passage Bio PASG Stock Holding History

Diadema Partners’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$153K Buy
+19,530
New +$202K 0.03% 127

Other funds holding PASG

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
YCM
Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Diadema Partners's PASG Position: Q1 2026 in Review

Diadema Partners opened a new position in Passage Bio (PASG) in Q1 2026: 19,530 shares worth $153K. The stake represents 0.03% of the portfolio and ranks #127 among its holdings.

35 funds tracked by Wall St. Rank hold PASG as of Q1 2026.

  • Diadema Partners held 19,530 shares of Passage Bio worth $153K as of Q1 2026.
  • Passage Bio was a new Diadema Partners position in Q1 2026.
  • Passage Bio made up 0.03% of Diadema Partners's portfolio in Q1 2026, its #127 holding.
  • 35 funds tracked by Wall St. Rank held Passage Bio as of Q1 2026.

Based on Diadema Partners's 13F filing for Q1 2026, filed 15 May 2026.